Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People
Sponsor: Boehringer Ingelheim
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PKs) of BI 3804379 in healthy male and female subjects following administration of single rising doses and administration of multiple rising doses.
Official title: A Phase 1, Randomised, Single-blind, Placebo-controlled Trial to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Rising Subcutaneous Doses of BI 3804379 in Healthy Male and Female Subjects
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
106
Start Date
2024-09-12
Completion Date
2028-03-20
Last Updated
2026-03-31
Healthy Volunteers
Yes
Conditions
Interventions
BI 3804379
BI 3804379
Placebo matching BI 3804379
Placebo matching BI 3804379
Locations (1)
SGS Life Science Services - Clinical Research
Edegem, Belgium